Last edition
News about "A3 Strategy and AI-Driven Drug Discovery "
Nona Biosciences Taps Dr. Hongjiang Miao to Advance A3 Strategy and AI-Driven Drug Discovery
Dr. Hongjiang Miao will lead the Nona AI team to advance the company's A3 (Antibody engineering × AI × Automation) strategy and further transform Nona into an AI-driven drug discovery company.
A3 Strategy And AI-Driven Drug Discovery | 04/12/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members